We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
India’s Ministry of Health and Family Welfare has established a transition timeline for its new medical device rules that go into force on April 1. Read More
The FDA issued draft guidances for devicemakers on using dual 510(k) and Clinical Laboratory Improvement Amendments (CLIA) waiver applications. Read More
A Kansas federal judge has certified two classes in an antitrust suit against Pfizer and Mylan over an alleged scheme to raise the price of EpiPen (epinephrine injection USP). Read More
FDA Commissioner Stephen Hahn said that the agency is not aware of any device shortages connected to the outbreak of the novel coronavirus, now known as COVID-19. Read More
The module on postmarket activities includes an overview of the quality system, exporting devices into the U.S., device recalls, inspections and global harmonization activities. Read More
The UK government has introduced a bill that would update the nation’s regulatory framework for medical devices by the end of the post-Brexit transition period which ends Dec. 31, 2020. Read More